ConductScience.org, home

Paper28028720

Liuwei Dihuang Pill () Treats Postmenopausal Osteoporosis with Shen (Kidney) Yin Deficiency via Janus Kinase/Signal Transducer and Activator of Transcription Signal Pathway by Up-regulating Cardiotrophin-Like Cytokine Factor 1 Expression.

Ge JR and 7 others. Chin J Integr Med, 2018. Cited by 35 papers, by iCite.

Cite this record

ConductScience Library. Liuwei Dihuang Pill () Treats Postmenopausal Osteoporosis with Shen (Kidney) Yin Deficiency via Janus Kinase/Signal Transducer and Activator of Transcription Signal Pathway by Up-regulating Cardiotrophin-Like Cytokine Factor 1 Expression. Papers, record 28028720. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28028720

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Liuwei Dihuang Pill () Treats Postmenopausal Osteoporosis with Shen (Kidney) Yin Deficiency via Janus Kinase/Signal Transducer and Activator of Transcription Signal Pathway by Up-regulating Cardiotrophin-Like Cytokine Factor 1 Expression.
PubMed
Journal
Chin J Integr Med
PubMed
Year
2018
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
35
iCite
Relative citation ratio, by iCite
2.05
iCite
Revised in PubMed
2018-11-13
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ge JRJi-Rong
2Xie LHLi-Hua
3Chen JJuan
4Li SQSheng-Qiang
5Xu HJHui-Juan
6Lai YLYu-Lian
7Qiu LLLong-Long
8Ni CBChen-Bo

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CytokinesMajor topic
Drugs, Chinese HerbalMajor topic
Janus KinasesMajor topic
Osteoporosis, PostmenopausalMajor topic
STAT Transcription FactorsMajor topic
Signal TransductionMajor topic
Up-RegulationMajor topic
Yin DeficiencyMajor topic
Female
Gene Expression Regulation
Humans
Middle Aged
RNA, Messenger

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT05125081Efficacy and Safety of Liuwei Dihuang Pill Versus Placebo in Presbycusis With Shen (Kidney)-Yin DeficiencyBackground

Source ClinicalTrials.gov

Download CSV of trials

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122322251Syndrome differentiation in modern research of traditional Chinese medicine.J Ethnopharmacol2012https://conductscience.org/library/papers/22322251PubMed
220652228Endogenous estrogen may prevent bone loss in postmenopausal hemodialysis patients throughout life.Osteoporos Int2011https://conductscience.org/library/papers/20652228PubMed
314632778Functional significance of novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) for human myeloma cell growth and survival.Br J Haematol2003https://conductscience.org/library/papers/14632778PubMed
412525111[Effect of liuwei dihuang decoction, on the cytokine expression in splenocytes in AA rats].Zhongguo Zhong Yao Za Zhi2001https://conductscience.org/library/papers/12525111PubMed
518619272[Experimental study on effect of Liuwei Dihuang Pill on HSC from mouse marrow].Zhong Yao Cai2008https://conductscience.org/library/papers/18619272PubMed
623665018AG490 inhibits NFATc1 expression and STAT3 activation during RANKL induced osteoclastogenesis.Biochem Biophys Res Commun2013https://conductscience.org/library/papers/23665018PubMed
716334720Effects of the combined therapy of acupuncture with herbal drugs on male immune infertility--a clinical report of 50 cases.J Tradit Chin Med2005https://conductscience.org/library/papers/16334720PubMed
825159583A study on proliferation and gene expression in normal human urothelial cells in culture.Tissue Eng Part A2015https://conductscience.org/library/papers/25159583PubMed
99275051Activation of the Janus kinase/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation.Endocrinology1997https://conductscience.org/library/papers/9275051PubMed
1021625400Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies.Cancer Manag Res2011https://conductscience.org/library/papers/21625400PubMed
1124530448The effects of Liuwei Dihuang on canonical Wnt/β-catenin signaling pathway in osteoporosis.J Ethnopharmacol2014https://conductscience.org/library/papers/24530448PubMed
1210500198Novel neurotrophin-1/B cell-stimulating factor-3: a cytokine of the IL-6 family.Proc Natl Acad Sci U S A1999https://conductscience.org/library/papers/10500198PubMed
1312372336Gp130 activation by soluble interleukin-6 receptor/interleukin-6 enhances osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells.Exp Cell Res2002https://conductscience.org/library/papers/12372336PubMed
1424073352Cold induced sweating syndrome with urinary system anomaly association.Case Rep Pediatr2013https://conductscience.org/library/papers/24073352PubMed
1510966616CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex.Nat Neurosci2000https://conductscience.org/library/papers/10966616PubMed
1612050122Genetics of osteoporosis.Endocr Rev2002https://conductscience.org/library/papers/12050122PubMed
1716679075A critical role for interleukin-6 family-mediated Stat3 activation in osteoblast differentiation and bone formation.Bone2006https://conductscience.org/library/papers/16679075PubMed
1824613578A new Turkish infant with clinical features of CS/CISS1 syndrome and homozygous CRLF1 mutation.Eur J Med Genet2014https://conductscience.org/library/papers/24613578PubMed
1925464594[Methods and evaluations on the sterioid-induced osteoporosis mice model with the type of Kidney-Yin deficiency].Zhongguo Gu Shang2014https://conductscience.org/library/papers/25464594PubMed
2025185711Impact of interferon-γ on hematopoiesis.Blood2014https://conductscience.org/library/papers/25185711PubMed

See all 39 referencesDownload CSV of references

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.

PMIDTitleJournalYearIn PapersSource
42982986Single-cell transcriptomic atlas of Kidney-Yang and Kidney-Yin deficiency syndromes reveals distinct osteoimmune-stromal programs underlying osteopenia and osteoporosis.MedScience2026https://conductscience.org/library/papers/42982986PubMed
42576484[Liuwei Dihuang Pill regulate osteoclast membrane fusion to improve postmenopausal osteoporosis in mice: the CLCF1/NFATc1 signaling axis as a therapeutic target].Nan Fang Yi Ke Da Xue Xue Bao2026https://conductscience.org/library/papers/42576484PubMed
42305445Plants used in medicines and foods in osteoporosis: mechanistic insights into bone-remodeling homeostasis and clinical evidence.Front Pharmacol2026https://conductscience.org/library/papers/42305445PubMed
41886086Stigmasterol upregulates Akt/mTOR/p70S6K signaling through SYVN1 to alleviate osteoporosis in ovariectomized rats.Eur J Nutr2026https://conductscience.org/library/papers/41886086PubMed
41749251Traditional Chinese Medicine for osteoporosis management: from molecular mechanisms to drug discovery.Chin Med2026https://conductscience.org/library/papers/41749251PubMed
39301568A review of the sources and pharmacological research of morroniside.Front Pharmacol2024https://conductscience.org/library/papers/39301568PubMed
39006498Augmented Cornus officinalis Levels in Liuwei Dihuang Decoction Inhibits Nucleus Pulposus Cell Pyroptosis to Enhance Therapeutic Efficacy Against Intervertebral Disc Degeneration.J Inflamm Res2024https://conductscience.org/library/papers/39006498PubMed
38256932Liuwei Dihuang Pills Enhance Osteogenic Differentiation in MC3T3-E1 Cells through the Activation of the Wnt/β-Catenin Signaling Pathway.Pharmaceuticals (Basel)2024https://conductscience.org/library/papers/38256932PubMed
38226230MEDAG expression in vitro and paeoniflorin alleviates bone loss by regulating the MEDAG/AMPK/PPARγ signaling pathway in vivo.Heliyon2024https://conductscience.org/library/papers/38226230PubMed
37700771Mechanisms of action and synergetic formulas of plant-based natural compounds from traditional Chinese medicine for managing osteoporosis: a literature review.Front Med (Lausanne)2023https://conductscience.org/library/papers/37700771PubMed
36624462Study on the treatment of postmenopausal osteoporosis with quercetin in Liuwei Dihuang Pill based on network pharmacology.J Orthop Surg Res2023https://conductscience.org/library/papers/36624462PubMed
36451445Network pharmacology-based strategy to investigate pharmacological mechanism of Liuwei Dihuang Pill against postmenopausal osteoporosis.Medicine (Baltimore)2022https://conductscience.org/library/papers/36451445PubMed
36210811Identification of kaempferol as an OSX upregulator by network pharmacology-based analysis of qianggu Capsule for osteoporosis.Front Pharmacol2022https://conductscience.org/library/papers/36210811PubMed
36185080Research on the Mechanism of Liuwei Dihuang Decoction for Osteoporosis Based on Systematic Biological Strategies.Evid Based Complement Alternat Med2022https://conductscience.org/library/papers/36185080PubMed
35571403Bromodomain-containing protein 4 activates cardiotrophin-like cytokine factor 1, an unfavorable prognostic biomarker, and promotes glioblastoma in vitro.Ann Transl Med2022https://conductscience.org/library/papers/35571403PubMed
35184684Chinese patent medicine for osteoporosis: a systematic review and meta-analysis.Bioengineered2022https://conductscience.org/library/papers/35184684PubMed
35055176CRLF1 and CLCF1 in Development, Health and Disease.Int J Mol Sci2022https://conductscience.org/library/papers/35055176PubMed
34880601Network Pharmacology and Experimental Validation to Reveal the Pharmacological Mechanisms of Liuwei Dihuang Decoction Against Intervertebral Disc Degeneration.Drug Des Devel Ther2021https://conductscience.org/library/papers/34880601PubMed
34239693Analysis of Molecular Mechanism of Erxian Decoction in Treating Osteoporosis Based on Formula Optimization Model.Oxid Med Cell Longev2021https://conductscience.org/library/papers/34239693PubMed
33430863Association of cardiotrophin-like cytokine factor 1 levels in peripheral blood mononuclear cells with bone mineral density and osteoporosis in postmenopausal women.BMC Musculoskelet Disord2021https://conductscience.org/library/papers/33430863PubMed

See all 29 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ASB151665PubTator's text mininghttps://conductscience.org/library/genes/51665NCBI Gene
CLCF123529PubTator's text mininghttps://conductscience.org/library/genes/23529NCBI Gene
JAK23717PubTator's text mininghttps://conductscience.org/library/genes/3717NCBI Gene
PROK260675PubTator's text mininghttps://conductscience.org/library/genes/60675NCBI Gene
STAT36774PubTator's text mininghttps://conductscience.org/library/genes/6774NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28028720

GET https://conductscience.org/api/papers/v1/28028720/references?page=2